Inventiva S.A. (IVA) Financials

IVA Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 286.6 million 219.3 million
March 31, 2026 285.2 million 318.5 million
Dec. 31, 2025 292.2 million 326.3 million
June 30, 2025 210.4 million 221.4 million

IVA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -67.4 million ?
March 31, 2026 -62.4 million ?
Dec. 31, 2025 -63.9 million ?
June 30, 2025 -63.6 million 9.4 million

IVA Net Income

No data available :(

IVA Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 189.5 million 60.9 million -
March 31, 2026 113.8 million - -
Dec. 31, 2025 116.5 million 29.1 million 5.6 million
June 30, 2025 143.9 million 60.8 million -

IVA Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 312.2 million
March 31, 2026 730.1 million
Dec. 31, 2025 748.0 million
June 30, 2025 128.3 million

IVA Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 194310 53.5 million 28.7 million -
March 31, 2026 220241 49.2 million - -
Dec. 31, 2025 225622 50.4 million 43.8 million 4.8 million
June 30, 2025 67183 51.0 million 19.6 million 869852

IVA Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 23131 1.6 million
March 31, 2026 32986 1.4 million
Dec. 31, 2025 33792 1.4 million
June 30, 2025 5.2 million 2.0 million

IVA

Price: $2.94

52 week price:
2.87
7.98

Earnings Per Share: -0.68 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 900

Market Capitalization: 174.9 million

Links: